EMEA-001357-PIP01-12-M02
Table of contents
Key facts
| Active substance |
|
| Therapeutic area |
Uro-nephrology
|
| Decision number |
P/0355/2018
|
| PIP number |
EMEA-001357-PIP01-12-M02
|
| Pharmaceutical form(s) |
Prolonged-release granules
|
| Condition(s) / indication(s) |
Treatment of renal tubular acidosis
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Advicenne Pharma
E-mail: contact@advicenne.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-001357-PIP01-12-M02
|
| Compliance opinion date |
15/11/2019
|
| Compliance outcome |
positive
|